Putting neoplasia risks attributed to immunomodulators and biologics into perspective and what to do if a malignancy develops

08/01/2018

Related Content

Gastroenterology
Gastroenterology
What Factors Influence Choice of 1st Therapy in IBD: How Can We Predict Response & Be Smarter?
07/31/2018
07/31/2018
Ophthalmology
Entropion
Ophthalmology
Entropion Surgery
11/14/2018
Surgical entropion repair, performed by Leonid Skorin Jr, DO, OD, MS, and filmed by Stephanie Norberg, OD.
11/14/2018
Hepatology
Hepatology
Arun Sanyal, MD, on Treatment Approaches to Targeting Metabolic Pathways in NAFLD
09/29/2020
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
09/29/2020
Cardiology
Cardiology
The C-Pulse Heart Assist Device: A Less Invasive Heart Failure Treatment
02/12/2015
Margarita Camacho, MD, and Mark J. Zucker, MD, JD, Barnabas Heart Center at Newark Beth Israel Medical Center describe the alternative option of a C-Pulse heart assist device when dealing...
02/12/2015
Gastroenterology
aibd
Gastroenterology
How to Institute Quality Improvement Initiatives In Your Practice
08/17/2018
08/17/2018